Abstract -Analysis of ESTs corresponding to human POLRMT for mitochondrial RNA polymerase suggested the existence of an alternative transcript. This mRNA, which contained 225 bp of the intron 1 proximal region, was detected in HeLa cells by reverse transcription-polymerase chain reaction. Alternative transcripts containing intron 1 were also found in mouse and rat cells. Moreover, a third transcript with an additional exon (142 bp), which originates from intron 2, was observed in mouse cells. In contrast to the major mRNA coding for the full-size RNA polymerase, the alternative transcripts code for a protein truncated at the N end and devoid of the mitochondrial targeting signal. The protein occurs exclusively in the nucleus and corresponds to new nuclear RNA polymerase IV, which was recently identified.
INTRODUCTION
The eukaryotic genome is transcribed by three RNA polymerases [1] . RNA polymerase I is responsible for synthesis of the 28S and 18S rRNAs [2] . RNA polymerase II synthesizes RNAs of all types, transcribing all protein-encoding genes and generating noncoding RNAs. RNA polymerase III transcribes genes for the 5S rRNA, tRNAs, 7SL RNA, U6 RNA, and some stable small RNAs involved in splicing [2] . In addition to these nuclear RNA polymerases, the eukaryotic cell possesses mitochondrial RNA polymerase (mtRNAP), which consists of a single subunit. It is known that mtRNAP is related to RNA polymerases of bacteria and bacteriophages and that its function is limited to transcription of only 37 mitochondrial genes [3] . There is evidence that mtRNAP appeared in the cell together with mitochondria, cell organelles displaying a similarity to archaebacteria. The human mtRNAP gene ( POLRMT ) contains 22 exons, belongs to the nuclear genome (like genes for most mitochondrial proteins), and maps to chromosome 19. POLRMT is transcribed by RNA polymerase II, and its protein product is transported into mitochondria due to the N-terminal signal peptide of 41 amino acid residues [3] . In addition, we found that PORMT codes for nuclear RNA polymerase IV; i.e., one gene codes for two RNA polymerases differing in location. In this work, we characterized the products of the alternative splicing of POLRMT mRNA.
EXPERIMENTAL
Cell lines and culturing. Human HeLa cells and mouse T3T fibroblasts were cultured in DMEM supplemented with 10% fetal bovine serum, 2 mM L -glutamine, 20 µ g/ml penicillin, and 20 µ g/ml streptomycin in a humid atmosphere containing 5% CO 2 at 37°ë .
RT-PCR.
To obtain cDNA, reverse transcription was carried out in 20 µ l of the reaction mixture with 3 µ g of total RNA and a SuperScript first-strand synthesis system as recommended by Invitrogen (United States). A 2-µ l aliquot was transferred into 50 µ l of the PCR mixture containing 100 ng of each specific primer. PCR was performed with Taq DNA polymerase (Invitrogen). The PCR conditions were based on the structures of specific primers. The amplification product was resolved electrophoretically in 1% agarose gel.
Alternative splicing products of the human mtR-NAP gene were detected with 5' primer 1 (5'-agaaggtaacacaaagggag), 3' primer 2 (5'-cccatctggaccttcctg), 5' primer 3 (5'-gtaatgtcggcactttgctg), 5' primer 4 (5'-gtggtttcttatgcagcctc), and 3' primer 5 (5'-atccttctccagtatctttgc).
Alternative splicing products of the mouse mtR-NAP gene were detected with 5' primer 1 (5'-ggaaggtaaaggagtgtc), 3' primer 2 (5'-cttcaccctcatctcag), 5' primer 3 (5'-atgtcggcgctccggtg), 5' primer 4 (5'-caagtatgtgcctgtatcaaac), and 3' primer 5 (5'-ctgcttttcctctgagttc).
Western blot analysis. Total protein and mitochondrial protein were heated at 95°ë , resolved by PAGE in 4-12% gel, and transferred onto a nitrocellulose membrane. The membrane was treated consecutively with antibodies against the C-terminal peptide of mtRNAP (kindly provided by G. Shadel, Atlanta, United States) and horseradish peroxidase-conjugated antibodies to rabbit immunoglobulins. 
RESULTS AND DISCUSSION
We have recently found that the transcription of some human genes is tolerant to α -amanitin (RNA polymerase II inhibitor [4] ). This finding has led to the discovery of nuclear RNA polymerase IV, which, along with mtRNAP, is encoded by POLRMT and synthesizes several protein-coding mRNAs [5] .
To elucidate the mechanism allowing one gene to code for two RNA polymerases differing in function and location, we studied the detailed structure of POLRMT alternative transcripts. The mitochondrial location of mtRNAP is determined by its N-terminal peptide. Hence, it is natural to assume that structurally different regions of the transcripts correspond to the proximal moiety of POLRMT . ESTs corresponding to the three proximal exons of POLRMT were extracted from GenBank and analyzed structurally. The structures of 19 ESTs corresponded to the known POLRMT transcript, which codes for mtRNAP. Yet three ESTs suggested an alternative transcript, in which the 225-bp proximal region of intron 1 is between exons 1 and 2 (Fig. 1a) . To verify the existence of such a transcript, PCR was carried out with cDNA obtained by reverse transcription of mRNA from HeLa cells. As primers, we used an oligonucleotide corresponding to the boundary between exon 1 and intron 1 and an oligonucleotide complementary to exon 3. The RT-PCR product of about 470 bp (Fig. 1b) was sequenced and proved to contain an intron 1 fragment (225 bp) adjacent to one primer, full-length exon 2 (105 bp), and an exon 3 fragment (136 bp) bounded by the other primer. The sequence of the RT-PCR product fully corresponded to the three POLRMT ESTs from GenBank (CN402441, BI830734, and BI831562) and one EST (hCT2251040) from the Celera Genomic database. To estimate the ratio between the alternative and major transcript, PCR was carried out with two direct primers (primer 3 directed to exon 1 and primer 4 directed to intron 1) and a common reverse primer corresponding to exon 3 (primer 5). We expected that a 390-bp product would be synthesized from the transcript coding for mtRNAP, and a 329-bp product would be synthesized from the alternative transcript. Products of these sizes were indeed amplified, and the intensity of the band corresponding to the alternative transcript amounted to 25 − 30% of that of the major transcript (Fig. 1b) . Evolutionary conservation of the two transcripts, which, for example, can be inferred from the presence of similar transcripts in mouse and rat cells, could testify to a functional significance of the alternative transcript of human POLRMT . Hence, we performed RT-PCR with primers directed to the boundary between exon 1 and intron 1 and to exon 3 of the mouse gene (Fig. 2) . Sequencing showed that the 855-bp amplification product contained full-length intron 1, although intron 2 was lacking. A fragment of 771 bp, which also contained intron 1, was similarly amplified with mRNA of Rat1 rat cells and the same primers (the corresponding regions are identical in the rat and mouse genes). Thus, the mechanism generating the alternative transcript of POLRMT is conserved in human, mouse, and rat. Moreover, analysis of the mouse EST database (GenBank) revealed a cDNA sequence (BY183086) containing a 142-bp region of intron 2. We tried to detect the corresponding mRNA in 3T3 cells and to estimate the ratio between the alternative and major transcripts by means of RT-PCR with three primers: a common distal primer corresponding to exon 3 (primer 5), primer 3 corresponding to the 5' end of exon 1, and primer 4 corresponding to the central region of intron 2 present in EST BY183086. Amplification yielded two expected fragments, 475 bp (major transcript) and 361 bp (alternative transcript); the ratio between them was approximately 1:5. Thus, we found that there are at least three alternative transcripts of mouse Polrmt .
Neither the alternative transcript of human POLRMT nor the two alternative transcripts of mouse Polrmt can be translated from the initiation codon utilized in mtRNAP synthesis, because the additional intron sequences result in numerous termination codons interrupting the reading frame. Hence, it is clear that protein synthesis is initiated at a downstream site and the resulting protein lacks the N-terminal peptide, which is responsible for the mitochondrial targeting of mtRNAP. The intracellular location of the protein was studied with two lentiviral vectors, which expressed the full-length cDNA of human mtRNAP [3] and a cDNA truncated at the proximal end and coding for a protein devoid of the N-terminal peptide. For convenience, the C-terminal region of each protein was supplemented with an artificial peptide with an antigenic epitope, Flag, which is recognized by anti-Flag antibodies. The constructs were introduced in HeLa cells, and protein products were analyzed by Western blotting with antibodies against mtRNAP and by immunofluorescence with anti-Flag antibodies 48 h after infection (Fig. 3) . Western blotting revealed two proteins in the total extract of control uninfected HeLa cells: one, 135 kDa, corresponded in size to mtRNAP, and the other was about 110 kDa. When cells were infected with the lentiviral vector carrying the full-length cDNA of mtRNAP, the intensity of the band corresponding to the 135-kDa protein increased substantially in the total extract, but not in the extract of isolated nuclei. When 
bp bp cells were infected with the vector containing the truncated cDNA, the band of the 110-kDa protein increased in intensity both in the total extract and in nuclei (Fig. 3a) . Thus, the truncated cDNA determined synthesis of a nuclear protein, while mtRNAP was not transported into the nucleus. This finding was verified by immunofluorescence analysis (Fig. 3b) , which revealed full-size mtRNAP only in mitochondria and the truncated protein only in the nucleus.
To summarize, we have recently identified a new human nuclear RNA polymerase, RNA polymerase IV, which synthesizes up to 3-5% of the total mRNA [5] . RNA polymerase IV is encoded by the alternative transcript of POLRMT . In this work, we characterized the products of alternative splicing of the POLRMT mRNA in human, mouse, and rat cells and confirmed that the protein encoded by the alternative transcript is localized in the nucleus.
